U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 202554

Expand all

LISINOPRIL (LISINOPRIL)
2.5MG
Marketing Status: Prescription
Active Ingredient: LISINOPRIL
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202554
Product Number: 001
Approval Date: Jul 30, 2013
Applicant Holder Full Name: ACCORD HEALTHCARE INC
Marketing Status:  Prescription
Patent and Exclusivity Information
LISINOPRIL (LISINOPRIL)
5MG
Marketing Status: Prescription
Active Ingredient: LISINOPRIL
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202554
Product Number: 002
Approval Date: Jul 30, 2013
Applicant Holder Full Name: ACCORD HEALTHCARE INC
Marketing Status:  Prescription
Patent and Exclusivity Information
LISINOPRIL (LISINOPRIL)
10MG
Marketing Status: Prescription
Active Ingredient: LISINOPRIL
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202554
Product Number: 003
Approval Date: Jul 30, 2013
Applicant Holder Full Name: ACCORD HEALTHCARE INC
Marketing Status:  Prescription
Patent and Exclusivity Information
LISINOPRIL (LISINOPRIL)
20MG
Marketing Status: Prescription
Active Ingredient: LISINOPRIL
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202554
Product Number: 004
Approval Date: Jul 30, 2013
Applicant Holder Full Name: ACCORD HEALTHCARE INC
Marketing Status:  Prescription
Patent and Exclusivity Information
LISINOPRIL (LISINOPRIL)
30MG
Marketing Status: Prescription
Active Ingredient: LISINOPRIL
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202554
Product Number: 005
Approval Date: Jul 30, 2013
Applicant Holder Full Name: ACCORD HEALTHCARE INC
Marketing Status:  Prescription
Patent and Exclusivity Information
LISINOPRIL (LISINOPRIL)
40MG
Marketing Status: Prescription
Active Ingredient: LISINOPRIL
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 40MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202554
Product Number: 006
Approval Date: Jul 30, 2013
Applicant Holder Full Name: ACCORD HEALTHCARE INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top